Levodopa-Benserazid Teva

Levodopa/Benserazide, the active ingredient in Levodopa-Benserazid Teva, is an antiparkinson agent presented as an oral dosage form for systemic use. It is employed to increase central dopamine levels, thereby improving motor function in patients with Parkinson's disease. The combination leverages benserazide to inhibit peripheral decarboxylation, allowing more levodopa to reach the brain, and thereby enhances therapeutic efficacy.

GNH USA supplies Levodopa-Benserazid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures reliable access to high‑quality medicines across regulated markets.

Levodopa/Benserazide is used in the management of Parkinsonian disorders, targeting motor symptoms associated with dopamine deficiency.

- Parkinson's disease: improves bradykinesia, rigidity, and resting tremor, enhancing overall motor function. - Drug‑induced motor fluctuations: reduces “off” periods and stabilizes symptom control in patients experiencing wearing‑off phenomena. - Early‑stage Parkinsonism: delays progression of motor impairment when initiated as part of combination therapy.

Levodopa/Benserazide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Severe hypotension or syncope - Psychiatric disturbances (hallucinations, confusion) - Cardiac arrhythmias - Neuroleptic malignant syndrome - Anaphylactic or severe allergic reactions

When prescribing Levodopa/Benserazide, clinicians should observe several safety considerations.

- Monitor blood pressure: watch for orthostatic hypotension especially during dose titration. - Assess psychiatric status: be alert for hallucinations, confusion, or mood changes. - Adjust dose in renal impairment: reduced clearance may increase plasma levels. - Avoid abrupt discontinuation: sudden withdrawal can precipitate severe worsening of Parkinsonian symptoms. - Use with caution in elderly patients: increased susceptibility to side effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Levodopa/Benserazide interacts with several medicines; awareness of these interactions helps maintain therapeutic effectiveness and safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine): risk of hypertensive crisis. - Antipsychotics that block dopamine receptors (e.g., haloperidol): markedly reduce drug efficacy. - Iron or calcium supplements taken concurrently: markedly decrease levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive orthostatic hypotension may occur. - Selective serotonin reuptake inhibitors (e.g., sertraline): potential for serotonin syndrome. - Carbamazepine or other enzyme inducers: may increase levodopa metabolism, lowering effectiveness.